A Randomized, Double-Blind, Multicenter Clinical Study Comparing the Efficacy and Safety of a Drug Combination of Lopinavir/Ritonavir-Azithromycin, Lopinavir/Ritonavir-Doxycycline, and Azithromycin-Hydroxychloroquine for Patients Diagnosed with Mild to Moderate COVID-19 Infections.
Purwati, Budiono, Rachman BE, Yulistiani, Miatmoko A, Nasronudin, Lardo S, Purnama YI, Laely M, Rochmad I, Ismail T, Wulandari S, Setyawan D, Rosyid AN, Setiawan HW, Wulaningrum PA, Asmarawati TP, Marfiani E, Yuniati SK, Fuadi MR, Endraswari PD, Purwaningsih, Hendrianto E, Karsari D, Dinaryanti A, Ertanti N, Ihsan IS, Purnama DS, Indrayani Y.
Purwati, et al. Among authors: endraswari pd.
Biochem Res Int. 2021 Feb 9;2021:6685921. doi: 10.1155/2021/6685921. eCollection 2021.
Biochem Res Int. 2021.
PMID: 33628506
Free PMC article.